Galena Biopharma Inc. | TalkMarkets

Latest Posts

Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update

Article By: The Life Sciences Report

Wednesday, March 9, 2016 5:47 PM EDT

Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.

In this article: SGYP, CRMD, ORMP, SRNE, ARRY, PTIE, AGEN, GALE, PPHM, EVOK, ADMA, AKBA, KPTI, VSTM, AST, RXDX, AGTC, WVE, FATE, FLKS, PIRS, ABEO

Read

The 2016 Small-Cap Biotech Watchlist Debuts At The Biotech Showcase

Article By: The Life Sciences Report

Wednesday, January 27, 2016 6:16 PM EDT

This may prove a challenging year for small-cap biotechs, but the five analysts who selected companies for inclusion on The Life Sciences Report's 2016 Small-Cap Biotech Watchlist believe these companies have a good producing value for investors.

In this article: AZN, NVO, SGYP, SNY, CRMD, ORMP, CMXHY, SRNE, ALNY, ARRY, INCY, IRWD, PTIE, REGN, VRTX, AGEN, GALE, GRFS, PPHM, EVOK, ADMA, AKBA, VSTM, AST, RXDX, AGTC, NK, WVE, FATE, FLKS

Read

Galena Biopharma Announces Reduction Of Cardiac Toxicity Study For Neuvax Trial

Article By: Terry Chrisomalis

Monday, August 24, 2015 6:39 PM EDT

Shares of Galena Biopharma (GALE) closed the day up 11%, after announcing reduction of cardiac toxicity study for Neuvax trial.

In this article: GALE

Read

Galena Biopharma Launches Anti-Nausea Drug Zuplenz

Article By: Terry Chrisomalis

Wednesday, July 29, 2015 2:31 PM EDT

Galena Biopharma shares are up 5% after announcing the launch of an anti-nausea drug known as Zuplenz, indicated for use in post-chemo, post-radiation and post-surgical patients.

In this article: GALE

Read